Rabbit Antithymocyte (rATG) Exposure and Outcomes after Hematopoietic Cell Transplantation: A Real World Experience from BMT CTN 1202

Background: Rabbit Antithymocyte globulin (rATG) is used to prevent graft rejection and graft versus host disease (GVHD) in hematopoietic cell transplantation (HCT). rATG pharmacokinetics are predicted by weight (

Saved in:
Bibliographic Details
Published in:Blood 2023-11, Vol.142 (Supplement 1), p.111-111
Main Authors: Lakkaraja, Madhavi, Mauguen, Audrey, Hosszu, Kinga K, McAvoy, Devin, Stewart, Valerie, Schmidt, Gabrielle, Levine, John, Perales, Miguel-Angel, Giralt, Sergio A., Baker, K. Scott, Boelens, Jaap Jan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Rabbit Antithymocyte globulin (rATG) is used to prevent graft rejection and graft versus host disease (GVHD) in hematopoietic cell transplantation (HCT). rATG pharmacokinetics are predicted by weight (
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2023-182352